MMP9 and neoplasm: Tumor MMP-9 expression is associated with poor outcomes in OPSCC, especially in HPV-negative disease, whereas Rgp immunoexpression in inflammatory cells is associated with better disease-specific survival, which can be utilized to predict prognosis [99].